Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
99.08 USD  +1.66 (+1.70%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 17, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Amgen, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Briefing: Leading Pharma Companies to Watch in Today's Market Session
February 05, 2013
from PR Newswire
Amgen To Webcast 2013 Business Review Meeting On February 7
January 31, 2013
from PR Newswire
Free Research Report on Marriott Vacations Worldwide Corp, Copart, Inc., Five Below, Inc., City National Corp. and Amgen Inc.
January 30, 2013
from PR Newswire
RBCC Partner N3D Could Revolutionize Toxicity Testing
January 30, 2013
from Business Wire News Releases
Emerging Growth Pharmaceutical Company Creates Gravitational Pull Towards Their Products
January 30, 2013
from PR Newswire
Critical Alerts For Amgen, FedEx, Hertz, Navistar, and Ship Finance International Released By InvestorsObserver
January 29, 2013
from PR Newswire
Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta® (pegfilgrastim) In Patients With Colorectal Cancer
January 26, 2013
Study Shows Neulasta Reduced the Incidence of Febrile Neutropenia in Patients With Colorectal Cancer Receiving FOLFOX or FOLFIRI and Bevacizumab Read More
from PR Newswire
Amgen Backs States' Efforts To Enact Biosimilar Legislation That Allows For Substitution And Supports Patient Safety
January 25, 2013
Biologics and Biosimilars are Complex Drugs, and Their Presence in the Marketplace Requires Appropriate Public Policy at the Federal and State Levels Read More
from PR Newswire
Amgen's Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51
January 23, 2013
Full Year 2012 GAAP EPS Were $5.52 Read More
from PR Newswire
Pill Economics - Research Report on Arena Pharmaceuticals, Inc. and Amgen, Inc.
January 23, 2013
Shares of Arena retraced double digits after questions on its weight loss pill arise, but is expected to bounce back soon. Amgen meanwhile is looking to maintain its valuation Read More
from PR Newswire
RBCC Visits Texas Genome-Mapping Target
January 22, 2013
from Business Wire News Releases
Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
January 18, 2013
from PR Newswire
Amgen Announces Top-Line Results Of Phase 3 Aranesp® (darbepoetin alfa) RED-HF® Trial
January 16, 2013
from PR Newswire
Amgen To Build State-Of-The-Art Manufacturing Facility In Singapore
January 16, 2013
from PR Newswire
RBCC Explores ‘Target-Rich Environment’ as Biotechnology Takes Over San Francisco
January 14, 2013
from Business Wire News Releases
RBCC Seeks Out New Breakthroughs at Biotech Showcase 2013
January 08, 2013
from Business Wire News Releases
Hagens Berman: Whistleblower Helps to Expose Alleged Illegal Amgen Marketing Scheme
January 03, 2013
from Business Wire News Releases
Amgen To Present At The 31st Annual J.P. Morgan Global Healthcare Conference
January 03, 2013
from PR Newswire
Critical Alerts For Citigroup, Amgen, Questcor Pharmaceuticals, Delphi Automotive, and Pan American Silver Released By InvestorsObserver
December 28, 2012
from PR Newswire
Amgen Finalizes Agreement Resolving Previously Announced Federal Investigations
December 19, 2012
$762 Million Agreement Covered by 3rd Quarter 2011 Charge Read More
from PR Newswire
RBCC’s Pending JV Partner Amarantus Licenses Alzheimer’s Blood Test Breakthrough
December 19, 2012
from Business Wire News Releases
Amgen Announces Appointment of Robert A. Eckert to Board of Directors
December 13, 2012
from PR Newswire
Amgen Names Robert A. Bradway Chairman of the Board Of Directors
December 13, 2012
Current Director Vance D. Coffman Named Lead Independent Director Read More
from PR Newswire
Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
December 13, 2012
from PR Newswire
Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
December 10, 2012
deCODE Genetics Will Provide Amgen With an Industry-Leading Ability to Identify and Validate Disease Targets in Human Populations Read More
from PR Newswire
Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting
December 05, 2012
from PR Newswire
RBCC Target Amarantus Wins MANF Patent Challenge in Europe
December 05, 2012
from Business Wire News Releases
RBCC JV Target Amarantus Presents Parkinson’s Therapeutic at CNS Summit
November 29, 2012
from Business Wire News Releases
RBCC JV Target Amarantus Explores Orphan Drug Designation for MANF
November 26, 2012
from Business Wire News Releases
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
November 23, 2012
Five Star Equities Provides Stock Research on Amgen and Regeneron Pharmaceuticals Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here